IL184145A - Transdermal therapeutic system comprising two compartments with activatable oversaturation and controlled permeation promotion and process for manufacturing the same - Google Patents

Transdermal therapeutic system comprising two compartments with activatable oversaturation and controlled permeation promotion and process for manufacturing the same

Info

Publication number
IL184145A
IL184145A IL184145A IL18414507A IL184145A IL 184145 A IL184145 A IL 184145A IL 184145 A IL184145 A IL 184145A IL 18414507 A IL18414507 A IL 18414507A IL 184145 A IL184145 A IL 184145A
Authority
IL
Israel
Prior art keywords
compartment
enhancer
verum
backing layer
sensitive adhesive
Prior art date
Application number
IL184145A
Other languages
English (en)
Other versions
IL184145A0 (en
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of IL184145A0 publication Critical patent/IL184145A0/en
Publication of IL184145A publication Critical patent/IL184145A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
IL184145A 2004-12-24 2007-06-21 Transdermal therapeutic system comprising two compartments with activatable oversaturation and controlled permeation promotion and process for manufacturing the same IL184145A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004062614A DE102004062614B4 (de) 2004-12-24 2004-12-24 Transdermales therapeutisches System mit aktivierbarer Übersättigung und kontrollierter Permeationförderung sowie Verfahren zu dessen Herstellung
PCT/EP2005/013133 WO2006072329A2 (de) 2004-12-24 2005-12-08 Transdermales therapeutisches system mit aktivierbarer übersättigung und kontrollierter permeationsförderung

Publications (2)

Publication Number Publication Date
IL184145A0 IL184145A0 (en) 2007-10-31
IL184145A true IL184145A (en) 2011-12-29

Family

ID=36579115

Family Applications (1)

Application Number Title Priority Date Filing Date
IL184145A IL184145A (en) 2004-12-24 2007-06-21 Transdermal therapeutic system comprising two compartments with activatable oversaturation and controlled permeation promotion and process for manufacturing the same

Country Status (12)

Country Link
US (1) US8883197B2 (ko)
EP (1) EP1827398B1 (ko)
JP (1) JP5185626B2 (ko)
KR (1) KR101259675B1 (ko)
CN (1) CN101087596B (ko)
AU (1) AU2005324182B2 (ko)
CA (1) CA2594065C (ko)
DE (1) DE102004062614B4 (ko)
ES (1) ES2401094T3 (ko)
IL (1) IL184145A (ko)
PL (1) PL1827398T3 (ko)
WO (1) WO2006072329A2 (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005050431A1 (de) 2005-10-21 2007-04-26 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreicherung lipophiler und/oder wenig hautpermeabler Wirkstoffe
DE102006054731B4 (de) 2006-11-21 2013-02-28 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie
WO2009005814A2 (en) * 2007-07-03 2009-01-08 Marchitto Kevin S Drug-delivery patch comprising a dissolvable layer and uses thereof
DE102009008256A1 (de) * 2009-02-10 2010-08-12 Lts Lohmann Therapie-Systeme Ag Prodrugs vom Typ N-hydroxylierter Amidine, Guanidine und/oder Aminohydrazone zur Applikation über die Haut
US8563031B2 (en) * 2010-05-27 2013-10-22 Absize, Inc. Piroxicam-containing matrix patches and methods for the topical treatment of acute and chronic pain and inflammation therewith
EP2654638A4 (en) * 2010-12-20 2014-07-02 Polytherapeutics Inc COMPOSITION FOR TRANSDERMAL ADMINISTRATION OF NON-STEROIDAL ANTI-INFLAMMATORY DRUG
JP6289378B2 (ja) 2011-12-12 2018-03-07 エルテーエス ローマン テラピー−ジステーメ アーゲー ブプレノルフィンを含む経皮送達システム
MA38698B1 (fr) 2013-06-04 2017-10-31 Lts Lohmann Therapie Systeme Ag Système d'administration transdermique
AU2017387141A1 (en) * 2016-12-29 2019-07-18 Pure Ratios Holdings, Inc. Modular transdermal delivery system and associated methods of manufacture and use
DE102017104026A1 (de) * 2017-02-27 2018-08-30 Lts Lohmann Therapie-Systeme Ag Nicotin enthaltendes transparentes transdermales therapeutisches System
US10953096B2 (en) 2017-04-28 2021-03-23 Nitto Denko Corporation Transdermal absorption preparation precursor
WO2019161131A1 (en) * 2018-02-14 2019-08-22 Barr Donna Marie Bandage for mixing separated liquids communicated to the skin of wearer
DE102018216244A1 (de) * 2018-09-24 2020-03-26 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit Barriereschicht

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4031894A (en) 1975-12-08 1977-06-28 Alza Corporation Bandage for transdermally administering scopolamine to prevent nausea
US4379454A (en) * 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
US4698062A (en) * 1985-10-30 1987-10-06 Alza Corporation Medical device for pulsatile transdermal delivery of biologically active agents
US4917676A (en) 1986-11-20 1990-04-17 Ciba-Geigy Corporation User-activated transdermal therapeutic system
IL84498A0 (en) * 1986-11-20 1988-04-29 Ciba Geigy Ag User-activated transdermal therapeutic system
US4911707A (en) * 1987-02-13 1990-03-27 Ciba-Geigy Corporation Monolithic user-activated transdermal therapeutic system
US4788064A (en) * 1987-07-31 1988-11-29 Warner-Lambert Company Transdermal delivery system
FR2633452B1 (fr) * 1988-06-28 1990-11-02 Doue Julien Dispositif de support pour un substrat mince, notamment en un materiau semiconducteur
DE3903794A1 (de) * 1989-02-09 1990-08-16 Lohmann Therapie Syst Lts Therapeutisches system zur transdermalen oder transmucosalen verabreichung von wirkstoffen und seine verwendung
DE3905050A1 (de) * 1989-02-18 1990-08-30 Lohmann Therapie Syst Lts Therapeutisches system zur verzoegerten und gesteuerten transdermalen oder transmucosalen verabreichung von wirkstoffen (ii)
JP3197420B2 (ja) * 1994-01-31 2001-08-13 三菱電機株式会社 画像符号化装置
US6019988A (en) * 1996-11-18 2000-02-01 Bristol-Myers Squibb Company Methods and compositions for enhancing skin permeation of drugs using permeation enhancers, when drugs and/or permeation enhancers are unstable in combination during long-term storage
CA2384986A1 (en) * 1999-09-15 2001-03-22 Alza Corporation Transdermal administration of n-(2,5-disubstituted phenyl)-n'-(3-substituted phenyl)-n'-methyl guanidines
DE19950066A1 (de) * 1999-10-16 2001-04-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einem Gehalt an Tulobuterol-hydrochlorid zur Verabreichung des Bronchodilatators Tulobuterol über die Haut
FR2801507B1 (fr) * 1999-11-30 2003-06-27 Pf Medicament Dispositif transdermique auto-adhesif comprenant un reservoir et une matrice contenant le meme principe actif, son procede de preparation et ses utilisations
DE10118282A1 (de) * 2001-04-12 2002-12-05 Lohmann Therapie Syst Lts Haftkleber auf Basis von Ethylen-Vinylacetat-Copolymeren und Klebharzen, für medizinische Verwendungszwecke
US7031894B2 (en) * 2002-01-16 2006-04-18 Timbre Technologies, Inc. Generating a library of simulated-diffraction signals and hypothetical profiles of periodic gratings
CN1164272C (zh) * 2002-10-31 2004-09-01 上海医药工业研究院 含有川芎嗪的组合物以及川芎嗪透皮贴剂及其制备方法

Also Published As

Publication number Publication date
JP5185626B2 (ja) 2013-04-17
KR20070089235A (ko) 2007-08-30
WO2006072329A2 (de) 2006-07-13
AU2005324182B2 (en) 2011-11-24
JP2008525334A (ja) 2008-07-17
EP1827398B1 (de) 2013-02-13
CA2594065C (en) 2014-01-28
KR101259675B1 (ko) 2013-05-06
DE102004062614A1 (de) 2006-07-06
WO2006072329A3 (de) 2006-12-28
PL1827398T3 (pl) 2013-07-31
CN101087596B (zh) 2013-01-02
US20080113013A1 (en) 2008-05-15
EP1827398A2 (de) 2007-09-05
ES2401094T3 (es) 2013-04-16
CA2594065A1 (en) 2006-07-13
AU2005324182A1 (en) 2006-07-13
CN101087596A (zh) 2007-12-12
DE102004062614B4 (de) 2011-12-29
US8883197B2 (en) 2014-11-11
IL184145A0 (en) 2007-10-31

Similar Documents

Publication Publication Date Title
US8883197B2 (en) Transdermal, therapeutic system with activatable oversaturation and controlled permeation promotion
EP0848608B1 (en) Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
AU2014276910B2 (en) Transdermal delivery system
US10729686B2 (en) Pharmaceutical compositions
US5683711A (en) Active ingredient patch
US6991095B1 (en) Packaging bag for plaster and packaged plaster
TWI426930B (zh) 含畢索普洛（ｂｉｓｏｐｒｏｌｏｌ）之貼附製劑
CA2550704C (en) Nicotine transdermal delivery system
WO1995016440A1 (fr) Timbre pour administration percutanee d'un medicament
JPH0446592B2 (ko)
US10532033B2 (en) Microreservoir system based on polysiloxanes and ambiphilic solvents
CA2845165C (en) Composition for enhancing transdermal absorption of drug and patch preparation
KR100624500B1 (ko) 레리세트론 전달용 경피치료시스템
US6106856A (en) Transdermal delivery of calcium channel blockers, such as nifedipine
JPH06199659A (ja) 経皮治療用装置
EP1196151B1 (en) Transdermal therapeutic system for administering a calcium antagonist

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees